Glycogen Synthase Kinase-3β: a novel therapeutic target for pancreatic cancer
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is the third leading cause of adult cancer death in the United States with a single-digit 5-year survival rate despite significant advances in understanding the genetics and biology of the disease....
Saved in:
Main Authors: | , |
---|---|
Format: | Text |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://pmc.ncbi.nlm.nih.gov/articles/PMC7539227/ https://pubmed.ncbi.nlm.nih.gov/32178549 http://dx.doi.org/10.1080/14728222.2020.1743681 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|